{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:57:30Z","timestamp":1780052250841,"version":"3.53.1"},"update-to":[{"DOI":"10.1371\/journal.ppat.1011873","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000}}],"reference-count":106,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T00:00:00Z","timestamp":1702944000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000072","name":"National Institute of Dental and Craniofacial Research","doi-asserted-by":"publisher","award":["R01DE025565"],"award-info":[{"award-number":["R01DE025565"]}],"id":[{"id":"10.13039\/100000072","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20GM134974"],"award-info":[{"award-number":["P20GM134974"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015194","name":"Feist-Weiller Cancer Center","doi-asserted-by":"publisher","award":["Carroll Feist predoctoral fellowship"],"award-info":[{"award-number":["Carroll Feist predoctoral fellowship"]}],"id":[{"id":"10.13039\/100015194","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LSU Center for Emerging Viral Threts","award":["predoctoral fellowship"],"award-info":[{"award-number":["predoctoral fellowship"]}]}],"content-domain":{"domain":["www.plospathogens.org"],"crossmark-restriction":false},"short-container-title":["PLoS Pathog"],"abstract":"<jats:p>As a human tumor virus, EBV is present as a latent infection in its associated malignancies where genetic and epigenetic changes have been shown to impede cellular differentiation and viral reactivation. We reported previously that levels of the Wnt signaling effector, lymphoid enhancer binding factor 1 (LEF1) increased following EBV epithelial infection and an epigenetic reprogramming event was maintained even after loss of the viral genome. Elevated LEF1 levels are also observed in nasopharyngeal carcinoma and Burkitt lymphoma. To determine the role played by LEF1 in the EBV life cycle, we used in silico analysis of EBV type 1 and 2 genomes to identify over 20 Wnt-response elements, which suggests that LEF1 may bind directly to the EBV genome and regulate the viral life cycle. Using CUT&amp;RUN-seq, LEF1 was shown to bind the latent EBV genome at various sites encoding viral lytic products that included the immediate early transactivator BZLF1 and viral primase BSLF1 genes. The LEF1 gene encodes various long and short protein isoforms. siRNA depletion of specific LEF1 isoforms revealed that the alternative-promoter derived isoform with an N-terminal truncation (\u0394N LEF1) transcriptionally repressed lytic genes associated with LEF1 binding. In addition, forced expression of the \u0394N LEF1 isoform antagonized EBV reactivation. As LEF1 repression requires histone deacetylase activity through either recruitment of or direct intrinsic histone deacetylase activity, siRNA depletion of LEF1 resulted in increased histone 3 lysine 9 and lysine 27 acetylation at LEF1 binding sites and across the EBV genome. Taken together, these results indicate a novel role for LEF1 in maintaining EBV latency and restriction viral reactivation via repressive chromatin remodeling of critical lytic cycle factors.<\/jats:p>","DOI":"10.1371\/journal.ppat.1011873","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T18:36:08Z","timestamp":1703010968000},"page":"e1011873","update-policy":"https:\/\/doi.org\/10.1371\/journal.ppat.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency"],"prefix":"10.1371","volume":"19","author":[{"given":"B. J. H.","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanchanjunga","family":"Prasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle L.","family":"Schaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3840-9189","authenticated-orcid":true,"given":"Rona S.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2023,12,19]]},"reference":[{"issue":"12","key":"ppat.1011873.ref001","doi-asserted-by":"crossref","first-page":"e80336","DOI":"10.1371\/journal.pone.0080336","article-title":"EBV infection is common in gingival epithelial cells of the periodontium and worsens during chronic periodontitis","volume":"8","author":"S Vincent-Bugnas","year":"2013","journal-title":"PLoS One"},{"issue":"8","key":"ppat.1011873.ref002","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1073\/pnas.2627966100","article-title":"Epstein-Barr virus-infected B cells expanding in germinal centers of infectious mononucleosis patients do not participate in the germinal center reaction","volume":"100","author":"J Kurth","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"ppat.1011873.ref003","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1073\/pnas.200366597","article-title":"Tonsillar memory B cells, latently infected with Epstein-Barr virus, express the restricted pattern of latent genes previously found only in Epstein-Barr virus-associated tumors","volume":"97","author":"GJ Babcock","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"ppat.1011873.ref004","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1074-7613(00)80622-6","article-title":"EBV persistence in memory B cells in vivo","volume":"9","author":"GJ Babcock","year":"1998","journal-title":"Immunity"},{"issue":"5942","key":"ppat.1011873.ref005","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/306480a0","article-title":"Replication of Epstein-Barr virus in human epithelial cells infected in vitro","volume":"306","author":"JW Sixbey","year":"1983","journal-title":"Nature"},{"issue":"46","key":"ppat.1011873.ref006","doi-asserted-by":"crossref","first-page":"16544","DOI":"10.1073\/pnas.1400818111","article-title":"Efficient replication of Epstein-Barr virus in stratified epithelium in vitro","volume":"111","author":"RM Temple","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"ppat.1011873.ref007","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1128\/JVI.79.2.1296-1307.2005","article-title":"Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo","volume":"79","author":"LL Laichalk","year":"2005","journal-title":"J Virol"},{"issue":"6","key":"ppat.1011873.ref008","doi-asserted-by":"crossref","first-page":"e1006404","DOI":"10.1371\/journal.ppat.1006404","article-title":"Hypoxia-inducible factor-1\u03b1 plays roles in Epstein-Barr virus\u2019s natural life cycle and tumorigenesis by inducing lytic infection through direct binding to the immediate-early BZLF1 gene promoter","volume":"13","author":"RJ Kraus","year":"2017","journal-title":"PLoS Pathog"},{"issue":"3","key":"ppat.1011873.ref009","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1073\/pnas.1919133117","article-title":"A promiscuous inflammasome sparks replication of a common tumor virus","volume":"117","author":"EM Burton","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"ppat.1011873.ref010","doi-asserted-by":"crossref","first-page":"e1005195","DOI":"10.1371\/journal.ppat.1005195","article-title":"Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells","volume":"11","author":"DM Nawandar","year":"2015","journal-title":"PLoS Pathog"},{"issue":"14","key":"ppat.1011873.ref011","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1128\/JVI.00546-13","article-title":"The B-cell-specific transcription factor and master regulator Pax5 promotes Epstein-Barr virus latency by negatively regulating the viral immediate early protein BZLF1","volume":"87","author":"RM Raver","year":"2013","journal-title":"J Virol"},{"issue":"3","key":"ppat.1011873.ref012","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1128\/JVI.02781-14","article-title":"Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters","volume":"89","author":"JA Reusch","year":"2015","journal-title":"J Virol"},{"issue":"11","key":"ppat.1011873.ref013","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.7150\/ijbs.16564","article-title":"Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis","volume":"12","author":"H Li","year":"2016","journal-title":"Int J Biol Sci"},{"issue":"7","key":"ppat.1011873.ref014","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1128\/jvi.62.7.2274-2284.1988","article-title":"A new Epstein-Barr virus transactivator, R, induces expression of a cytoplasmic early antigen","volume":"62","author":"JM Hardwick","year":"1988","journal-title":"J Virol"},{"issue":"7","key":"ppat.1011873.ref015","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1128\/jvi.63.7.3109-3116.1989","article-title":"The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle","volume":"63","author":"CM Rooney","year":"1989","journal-title":"J Virol"},{"issue":"21","key":"ppat.1011873.ref016","doi-asserted-by":"crossref","first-page":"12825","DOI":"10.1128\/JVI.02139-14","article-title":"Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex","volume":"88","author":"V Aubry","year":"2014","journal-title":"J Virol"},{"issue":"12","key":"ppat.1011873.ref017","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1056\/NEJMra2025746","article-title":"Burkitt\u2019s Lymphoma","volume":"387","author":"M Roschewski","year":"2022","journal-title":"N Engl J Med"},{"issue":"17","key":"ppat.1011873.ref018","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1158\/1078-0432.CCR-06-2823","article-title":"Age-related EBV-associated B-cell lymphoproliferative disorders constitute a distinct clinicopathologic group: a study of 96 patients","volume":"13","author":"T Oyama","year":"2007","journal-title":"Clin Cancer Res"},{"issue":"4","key":"ppat.1011873.ref019","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<375::AID-IJC1>3.0.CO;2-T","article-title":"Epstein-Barr virus-associated Hodgkin\u2019s disease: epidemiologic characteristics in international data","volume":"70","author":"SL Glaser","year":"1997","journal-title":"Int J Cancer"},{"key":"ppat.1011873.ref020","first-page":"372","article-title":"Epstein-Barr virus infection and nasopharyngeal carcinoma","author":"SW Tsao","year":"2017","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"3","key":"ppat.1011873.ref021","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1053\/j.gastro.2009.05.001","article-title":"Meta-analysis shows that prevalence of Epstein-Barr virus-positive gastric cancer differs based on sex and anatomic location","volume":"137","author":"G Murphy","year":"2009","journal-title":"Gastroenterology"},{"issue":"2","key":"ppat.1011873.ref022","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-6143.2006.01650.x","article-title":"Epstein-Barr virus: evasive maneuvers in the development of PTLD","volume":"7","author":"AL Snow","year":"2007","journal-title":"Am J Transplant"},{"issue":"9","key":"ppat.1011873.ref023","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1128\/JVI.06768-11","article-title":"Epigenetic histone modification of Epstein-Barr virus BZLF1 promoter during latency and reactivation in Raji cells","volume":"86","author":"T Murata","year":"2012","journal-title":"J Virol"},{"key":"ppat.1011873.ref024","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coviro.2021.11.013","article-title":"Epigenetic control of the Epstein-Barr lifecycle","volume":"52","author":"R Guo","year":"2022","journal-title":"Curr Opin Virol"},{"issue":"5","key":"ppat.1011873.ref025","doi-asserted-by":"crossref","DOI":"10.3390\/v13050846","article-title":"Inflammasome, the Constitutive Heterochromatin Machinery, and Replication of an Oncogenic Herpesvirus","volume":"13","author":"S Bhaduri-McIntosh","year":"2021","journal-title":"Viruses"},{"issue":"3","key":"ppat.1011873.ref026","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1101\/gr.083550.108","article-title":"The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer","volume":"19","author":"AF Fernandez","year":"2009","journal-title":"Genome Res"},{"issue":"19","key":"ppat.1011873.ref027","doi-asserted-by":"crossref","first-page":"11442","DOI":"10.1128\/JVI.00972-14","article-title":"Genome-wide DNA methylation as an epigenetic consequence of Epstein-Barr virus infection of immortalized keratinocytes","volume":"88","author":"CE Birdwell","year":"2014","journal-title":"J Virol"},{"issue":"10","key":"ppat.1011873.ref028","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1128\/JVI.00116-08","article-title":"Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virus-infected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors","volume":"82","author":"JK Countryman","year":"2008","journal-title":"J Virol"},{"issue":"3","key":"ppat.1011873.ref029","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/JVI.06334-11","article-title":"Dynamic chromatin environment of key lytic cycle regulatory regions of the Epstein-Barr virus genome","volume":"86","author":"S Ramasubramanyan","year":"2012","journal-title":"J Virol"},{"issue":"1","key":"ppat.1011873.ref030","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0042-6822(79)90455-0","article-title":"Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate","volume":"94","author":"J Luka","year":"1979","journal-title":"Virology"},{"key":"ppat.1011873.ref031","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0065-230X(06)97004-3","article-title":"Lytic cycle switches of oncogenic human gammaherpesviruses","volume":"97","author":"G Miller","year":"2007","journal-title":"Adv Cancer Res"},{"issue":"1","key":"ppat.1011873.ref032","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ijc.29698","article-title":"Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir","volume":"138","author":"KF Hui","year":"2016","journal-title":"Int J Cancer"},{"issue":"7","key":"ppat.1011873.ref033","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1128\/jvi.69.7.4158-4165.1995","article-title":"YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter","volume":"69","author":"EA Montalvo","year":"1995","journal-title":"J Virol"},{"issue":"10","key":"ppat.1011873.ref034","doi-asserted-by":"crossref","first-page":"8230","DOI":"10.1128\/JVI.72.10.8230-8239.1998","article-title":"Identification of a negative cis element within the ZII domain of the Epstein-Barr virus lytic switch BZLF1 gene promoter","volume":"72","author":"P Liu","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"ppat.1011873.ref035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/emboj\/16.1.143","article-title":"Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member","volume":"16","author":"S Liu","year":"1997","journal-title":"Embo j"},{"issue":"1","key":"ppat.1011873.ref036","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/viro.1996.8371","article-title":"Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter","volume":"228","author":"S Liu","year":"1997","journal-title":"Virology"},{"issue":"25","key":"ppat.1011873.ref037","doi-asserted-by":"crossref","first-page":"22007","DOI":"10.1074\/jbc.M110.199836","article-title":"in the maintenance of Epstein-Barr virus latency","volume":"286","author":"T Murata","year":"2011","journal-title":"J Biol Chem"},{"issue":"10","key":"ppat.1011873.ref038","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ng1424","article-title":"The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome","volume":"36","author":"PM Bhende","year":"2004","journal-title":"Nat Genet"},{"issue":"3","key":"ppat.1011873.ref039","article-title":"Epstein-Barr Virus-Induced Epigenetic Pathogenesis of Viral-Associated Lymphoepithelioma-Like Carcinomas and Natural Killer\/T-Cell Lymphomas","volume":"7","author":"L Li","year":"2018","journal-title":"Pathogens"},{"issue":"12","key":"ppat.1011873.ref040","doi-asserted-by":"crossref","first-page":"10417","DOI":"10.18632\/oncotarget.23824","article-title":"Epstein-Barr virus stably confers an invasive phenotype to epithelial cells through reprogramming of the WNT pathway","volume":"9","author":"CE Birdwell","year":"2018","journal-title":"Oncotarget"},{"issue":"10","key":"ppat.1011873.ref041","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1242\/dev.126.10.2285","article-title":"beta-catenin signalling modulates proliferative potential of human epidermal keratinocytes independently of intercellular adhesion","volume":"126","author":"AJ Zhu","year":"1999","journal-title":"Development"},{"issue":"3","key":"ppat.1011873.ref042","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/abbs\/37.3.173","article-title":"Alterations of lymphoid enhancer factor-1 isoform expression in solid tumors and acute leukemias","volume":"37","author":"W Wang","year":"2005","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"issue":"10","key":"ppat.1011873.ref043","doi-asserted-by":"crossref","first-page":"e76596","DOI":"10.1371\/journal.pone.0076596","article-title":"Knockdown of lymphoid enhancer factor 1 inhibits colon cancer progression in vitro and in vivo","volume":"8","author":"WJ Wang","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"ppat.1011873.ref044","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.3892\/ijo.2014.2342","article-title":"Oncogenic effects of WNT5A in Epstein-Barr virus-associated nasopharyngeal carcinoma","volume":"44","author":"LF Yap","year":"2014","journal-title":"Int J Oncol"},{"issue":"3","key":"ppat.1011873.ref045","first-page":"1124","article-title":"LEF1 targeting EMT in prostate cancer invasion is mediated by miR-181a","volume":"5","author":"J Liang","year":"2015","journal-title":"Am J Cancer Res"},{"issue":"13","key":"ppat.1011873.ref046","doi-asserted-by":"crossref","first-page":"6618","DOI":"10.1093\/nar\/gkt410","article-title":"IGF2BP1 promotes mesenchymal cell properties and migration of tumor-derived cells by enhancing the expression of LEF1 and SNAI2 (SLUG)","volume":"41","author":"A Zirkel","year":"2013","journal-title":"Nucleic Acids Res"},{"issue":"15","key":"ppat.1011873.ref047","doi-asserted-by":"crossref","first-page":"8358","DOI":"10.1073\/pnas.150152697","article-title":"Association of Smads with lymphoid enhancer binding factor 1\/T cell-specific factor mediates cooperative signaling by the transforming growth factor-beta and wnt pathways","volume":"97","author":"E Labb\u00e9","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ppat.1011873.ref048","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ajpath.2012.12.013","article-title":"Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt\u2019s lymphoma","volume":"182","author":"N Walther","year":"2013","journal-title":"Am J Pathol"},{"issue":"11","key":"ppat.1011873.ref049","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/modpathol.2011.103","article-title":"Nuclear overexpression of lymphoid-enhancer-binding factor 1 identifies chronic lymphocytic leukemia\/small lymphocytic lymphoma in small B-cell lymphomas","volume":"24","author":"B Tandon","year":"2011","journal-title":"Mod Pathol"},{"key":"ppat.1011873.ref050","article-title":"Lef1 expression in fibroblasts maintains developmental potential in adult skin to regenerate wounds","volume":"9","author":"QM Phan","year":"2020","journal-title":"Elife"},{"issue":"12","key":"ppat.1011873.ref051","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.jfma.2013.07.012","article-title":"Expression of LEF1 is an independent prognostic factor for patients with oral squamous cell carcinoma","volume":"113","author":"MC Su","year":"2014","journal-title":"J Formos Med Assoc"},{"issue":"6592","key":"ppat.1011873.ref052","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/382638a0","article-title":"Functional interaction of beta-catenin with the transcription factor LEF-1","volume":"382","author":"J Behrens","year":"1996","journal-title":"Nature"},{"issue":"12a","key":"ppat.1011873.ref053","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1101\/gad.7.12a.2418","article-title":"The hLEF\/TCF-1 alpha HMG protein contains a context-dependent transcriptional activation domain that induces the TCR alpha enhancer in T cells","volume":"7","author":"P Carlsson","year":"1993","journal-title":"Genes Dev"},{"issue":"18","key":"ppat.1011873.ref054","doi-asserted-by":"crossref","first-page":"6882","DOI":"10.1128\/MCB.20.18.6882-6890.2000","article-title":"Beta-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator","volume":"20","author":"AN Billin","year":"2000","journal-title":"Mol Cell Biol"},{"issue":"6","key":"ppat.1011873.ref055","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/ni.3456","article-title":"Tcf1 and Lef1 transcription factors establish CD8(+) T cell identity through intrinsic HDAC activity","volume":"17","author":"S Xing","year":"2016","journal-title":"Nat Immunol"},{"issue":"9","key":"ppat.1011873.ref056","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1093\/nar\/28.9.1994","article-title":"The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing","volume":"28","author":"K Hovanes","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"ppat.1011873.ref057","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1002\/dvdy.20275","article-title":"TGF-beta induces novel Lef-1 splice variants through a Smad-independent signaling pathway","volume":"232","author":"P Cordray","year":"2005","journal-title":"Dev Dyn"},{"issue":"1","key":"ppat.1011873.ref058","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ng0501-53","article-title":"Beta-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer","volume":"28","author":"K Hovanes","year":"2001","journal-title":"Nat Genet"},{"issue":"10","key":"ppat.1011873.ref059","doi-asserted-by":"crossref","first-page":"e1005900","DOI":"10.1371\/journal.ppat.1005900","article-title":"Fine-Tuning of the Kaposi\u2019s Sarcoma-Associated Herpesvirus Life Cycle in Neighboring Cells through the RTA-JAG1-Notch Pathway","volume":"12","author":"S Li","year":"2016","journal-title":"PLoS Pathog"},{"issue":"3","key":"ppat.1011873.ref060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i3.10","article-title":"Cell-context dependent TCF\/LEF expression and function: alternative tales of repression, de-repression and activation potentials","volume":"21","author":"CD Mao","year":"2011","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"11","key":"ppat.1011873.ref061","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1007\/s13277-014-2466-z","article-title":"LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal","volume":"35","author":"X Gao","year":"2014","journal-title":"Tumour Biol"},{"issue":"12b","key":"ppat.1011873.ref062","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1101\/gad.5.12b.2567","article-title":"DNA-binding properties of the HMG domain of the lymphoid-specific transcriptional regulator LEF-1","volume":"5","author":"K Giese","year":"1991","journal-title":"Genes Dev"},{"issue":"9","key":"ppat.1011873.ref063","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1073\/pnas.0611576104","article-title":"Serial analysis of chromatin occupancy identifies beta-catenin target genes in colorectal carcinoma cells","volume":"104","author":"GS Yochum","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"ppat.1011873.ref064","doi-asserted-by":"crossref","first-page":"8352","DOI":"10.1128\/MCB.02132-06","article-title":"A unique DNA binding domain converts T-cell factors into strong Wnt effectors","volume":"27","author":"FA Atcha","year":"2007","journal-title":"Mol Cell Biol"},{"issue":"26","key":"ppat.1011873.ref065","doi-asserted-by":"crossref","first-page":"14973","DOI":"10.1073\/pnas.261574498","article-title":"Elevated expression of axin2 and hnkd mRNA provides evidence that Wnt\/beta -catenin signaling is activated in human colon tumors","volume":"98","author":"D Yan","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1011873.ref066","first-page":"6","article-title":"An efficient targeted nuclease strategy for high-resolution mapping of DNA binding sites","author":"PJ Skene","year":"2017","journal-title":"Elife"},{"issue":"9","key":"ppat.1011873.ref067","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1261\/rna.7226105","article-title":"An internal ribosome entry site mediates translation of lymphoid enhancer factor-1","volume":"11","author":"J Jimenez","year":"2005","journal-title":"Rna"},{"issue":"4","key":"ppat.1011873.ref068","article-title":"Quantitative profiling of in vivo-assembled RNA-protein complexes using a novel integrated proteomic approach","volume":"10","author":"BP Tsai","year":"2011","journal-title":"Mol Cell Proteomics"},{"issue":"4","key":"ppat.1011873.ref069","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1128\/jvi.70.4.2545-2555.1996","article-title":"Activation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F","volume":"70","author":"C Liu","year":"1996","journal-title":"J Virol"},{"issue":"6","key":"ppat.1011873.ref070","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1128\/jvi.65.6.2868-2874.1991","article-title":"Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia","volume":"65","author":"LS Young","year":"1991","journal-title":"J Virol"},{"issue":"8","key":"ppat.1011873.ref071","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1158\/0008-5472.CAN-08-3380","article-title":"LEF1 in androgen-independent prostate cancer: regulation of androgen receptor expression, prostate cancer growth, and invasion","volume":"69","author":"Y Li","year":"2009","journal-title":"Cancer Res"},{"issue":"3","key":"ppat.1011873.ref072","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1083\/jcb.90.3.732","article-title":"Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia","volume":"90","author":"S Banks-Schlegel","year":"1981","journal-title":"J Cell Biol"},{"issue":"3","key":"ppat.1011873.ref073","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/0092-8674(79)90123-5","article-title":"Presence in human epidermal cells of a soluble protein precursor of the cross-linked envelope: activation of the cross-linking by calcium ions","volume":"18","author":"RH Rice","year":"1979","journal-title":"Cell"},{"issue":"4","key":"ppat.1011873.ref074","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nsmb912","article-title":"Beta-catenin directly displaces Groucho\/TLE repressors from Tcf\/Lef in Wnt-mediated transcription activation","volume":"12","author":"DL Daniels","year":"2005","journal-title":"Nat Struct Mol Biol"},{"key":"ppat.1011873.ref075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/1471-2407-9-159","article-title":"Groucho binds two conserved regions of LEF-1 for HDAC-dependent repression","volume":"9","author":"L Arce","year":"2009","journal-title":"BMC Cancer"},{"issue":"7","key":"ppat.1011873.ref076","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/nar\/29.7.1410","article-title":"All Tcf HMG box transcription factors interact with Groucho-related co-repressors","volume":"29","author":"H Brantjes","year":"2001","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"ppat.1011873.ref077","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/jcb.20604","article-title":"Translating the histone code into leukemia","volume":"96","author":"BE Linggi","year":"2005","journal-title":"J Cell Biochem"},{"issue":"4","key":"ppat.1011873.ref078","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.molcel.2020.03.025","article-title":"MYC Controls the Epstein-Barr Virus Lytic Switch","volume":"78","author":"R Guo","year":"2020","journal-title":"Mol Cell"},{"issue":"4","key":"ppat.1011873.ref079","first-page":"801","article-title":"Lymphoid enhancer factor 1 makes cells resistant to transforming growth factor beta-induced repression of c-myc","volume":"63","author":"T Sasaki","year":"2003","journal-title":"Cancer Res"},{"issue":"4","key":"ppat.1011873.ref080","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/s41375-019-0635-1","article-title":"Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis","volume":"34","author":"K Feder","year":"2020","journal-title":"Leukemia"},{"issue":"21","key":"ppat.1011873.ref081","doi-asserted-by":"crossref","first-page":"11648","DOI":"10.1128\/JVI.78.21.11648-11655.2004","article-title":"Accumulation of cytoplasmic beta-catenin and nuclear glycogen synthase kinase 3beta in Epstein-Barr virus-infected cells","volume":"78","author":"DN Everly","year":"2004","journal-title":"J Virol"},{"issue":"22","key":"ppat.1011873.ref082","doi-asserted-by":"crossref","first-page":"12276","DOI":"10.1128\/JVI.77.22.12276-12284.2003","article-title":"Epstein-Barr virus latent membrane protein 2A activates beta-catenin signaling in epithelial cells","volume":"77","author":"JA Morrison","year":"2003","journal-title":"J Virol"},{"issue":"26","key":"ppat.1011873.ref083","doi-asserted-by":"crossref","first-page":"15572","DOI":"10.1073\/pnas.2636947100","article-title":"Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes","volume":"100","author":"J Shackelford","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ppat.1011873.ref084","doi-asserted-by":"crossref","first-page":"105082","DOI":"10.1016\/j.antiviral.2021.105082","article-title":"Wnt antagonists suppress herpes simplex virus type 1 productive infection","volume":"191","author":"KS Harrison","year":"2021","journal-title":"Antiviral Res"},{"issue":"15","key":"ppat.1011873.ref085","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.1128\/JVI.01197-10","article-title":"Transforming growth factor beta-induced reactivation of Epstein-Barr virus involves multiple Smad-binding elements cooperatively activating expression of the latent-lytic switch BZLF1 gene","volume":"85","author":"T Iempridee","year":"2011","journal-title":"J Virol"},{"issue":"11","key":"ppat.1011873.ref086","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007906","article-title":"TCF\/LEFs and Wnt signaling in the nucleus","volume":"4","author":"KM Cadigan","year":"2012","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"51","key":"ppat.1011873.ref087","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1021\/bi801610c","article-title":"Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors","volume":"47","author":"DP Dowling","year":"2008","journal-title":"Biochemistry"},{"issue":"9","key":"ppat.1011873.ref088","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1038\/sj.embor.7401047","article-title":"Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex","volume":"8","author":"A Vannini","year":"2007","journal-title":"EMBO Rep"},{"issue":"7","key":"ppat.1011873.ref089","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.str.2004.04.012","article-title":"Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases","volume":"12","author":"JR Somoza","year":"2004","journal-title":"Structure"},{"issue":"4","key":"ppat.1011873.ref090","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cell.2013.09.053","article-title":"Super-enhancers in the control of cell identity and disease","volume":"155","author":"D Hnisz","year":"2013","journal-title":"Cell"},{"issue":"3","key":"ppat.1011873.ref091","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/ng1966","article-title":"Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome","volume":"39","author":"ND Heintzman","year":"2007","journal-title":"Nat Genet"},{"issue":"50","key":"ppat.1011873.ref092","doi-asserted-by":"crossref","first-page":"21931","DOI":"10.1073\/pnas.1016071107","article-title":"Histone H3K27ac separates active from poised enhancers and predicts developmental state","volume":"107","author":"MP Creyghton","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"ppat.1011873.ref093","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm3890","article-title":"Histone core modifications regulating nucleosome structure and dynamics","volume":"15","author":"P Tessarz","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"ppat.1011873.ref094","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1128\/JVI.74.2.710-720.2000","article-title":"Histone acetylation and reactivation of Epstein-Barr virus from latency","volume":"74","author":"PJ Jenkins","year":"2000","journal-title":"J Virol"},{"issue":"8","key":"ppat.1011873.ref095","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1101\/gad.9.8.995","article-title":"Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions","volume":"9","author":"K Giese","year":"1995","journal-title":"Genes Dev"},{"issue":"6543","key":"ppat.1011873.ref096","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/376791a0","article-title":"Structural basis for DNA bending by the architectural transcription factor LEF-1","volume":"376","author":"JJ Love","year":"1995","journal-title":"Nature"},{"issue":"8","key":"ppat.1011873.ref097","doi-asserted-by":"crossref","first-page":"5129","DOI":"10.4049\/jimmunol.0802744","article-title":"Lymphoid enhancer binding factor 1 regulates transcription through gene looping","volume":"183","author":"K Yun","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"ppat.1011873.ref098","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-021-27894-1","article-title":"The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity","volume":"13","author":"SM Morgan","year":"2022","journal-title":"Nat Commun"},{"issue":"2","key":"ppat.1011873.ref099","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.chom.2012.06.008","article-title":"An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions","volume":"12","author":"A Arvey","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"4","key":"ppat.1011873.ref100","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.3390\/v5041042","article-title":"Interpreting the Epstein-Barr Virus (EBV) epigenome using high-throughput data","volume":"5","author":"A Arvey","year":"2013","journal-title":"Viruses"},{"issue":"5","key":"ppat.1011873.ref101","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.molcel.2015.04.001","article-title":"SMADs and YAP compete to control elongation of \u03b2-catenin:LEF-1-recruited RNAPII during hESC differentiation","volume":"58","author":"C Estar\u00e1s","year":"2015","journal-title":"Mol Cell"},{"key":"ppat.1011873.ref102","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.virol.2017.04.006","article-title":"PARP1 restricts Epstein Barr Virus lytic reactivation by binding the BZLF1 promoter","volume":"507","author":"LN Lupey-Green","year":"2017","journal-title":"Virology"},{"issue":"2","key":"ppat.1011873.ref103","first-page":"476","article-title":"Abrogation of the retinoblastoma tumor suppressor checkpoint during keratinocyte immortalization is not sufficient for induction of centrosome-mediated genomic instability","volume":"63","author":"SO Piboonniyom","year":"2003","journal-title":"Cancer Res"},{"issue":"14","key":"ppat.1011873.ref104","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also plays a role in attachment of virus to epithelial cells","volume":"74","author":"SJ Molesworth","year":"2000","journal-title":"J Virol"},{"issue":"3","key":"ppat.1011873.ref105","doi-asserted-by":"crossref","first-page":"100750","DOI":"10.1016\/j.xpro.2021.100750","article-title":"A modified CUT&RUN protocol and analysis pipeline to identify transcription factor binding sites in human cell lines","volume":"2","author":"NR Kong","year":"2021","journal-title":"STAR Protoc"},{"key":"ppat.1011873.ref106","article-title":"A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency [Dataset]","author":"Rona Scott","year":"2023","journal-title":"Dryad"}],"updated-by":[{"DOI":"10.1371\/journal.ppat.1011873","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000}}],"container-title":["PLOS Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T18:36:51Z","timestamp":1704307011000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.ppat.1011873"}},"subtitle":[],"editor":[{"given":"Paul M.","family":"Lieberman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,19]]},"references-count":106,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12,19]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.ppat.1011873","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.ppat.1011873","asserted-by":"object"}]},"ISSN":["1553-7374"],"issn-type":[{"value":"1553-7374","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,19]]}}}